BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22906483)

  • 1. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
    Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
    Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands.
    Mollers M; Boot Hein J; Vriend Henrike J; King Audrey J; van den Broek Ingrid VF; van Bergen Jan EA; Brink Antoinette AT; Wolffs Petra FG; Hoebe Christian JP; Meijer Chris JL; van der Sande Marianne AB; de Melker Hester E
    Vaccine; 2013 Jan; 31(2):394-401. PubMed ID: 23146675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus infection prior to coitarche.
    Doerfler D; Bernhaus A; Kottmel A; Sam C; Koelle D; Joura EA
    Am J Obstet Gynecol; 2009 May; 200(5):487.e1-5. PubMed ID: 19268884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-specific human papillomavirus infections among young heterosexual male and female STI clinic attendees.
    Vriend HJ; Boot HJ; van der Sande MA; ;
    Sex Transm Dis; 2012 Jan; 39(1):72-8. PubMed ID: 22183851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
    Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
    J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands.
    Lenselink CH; Melchers WJ; Quint WG; Hoebers AM; Hendriks JC; Massuger LF; Bekkers RL
    PLoS One; 2008; 3(11):e3743. PubMed ID: 19011683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.
    Mollers M; King AJ; Knol MJ; Scherpenisse M; Meijer CJ; van der Klis FR; de Melker HE
    Vaccine; 2015 May; 33(23):2678-83. PubMed ID: 25887090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grujnberga V; Grujnberg A; Juschenko A; Johansson B; Tosi P; Cintorino M; Santopietro R; Syrjänen K
    Sex Transm Dis; 2003 Sep; 30(9):680-4. PubMed ID: 12972789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
    Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papilloma Virus infection in sexually active adolescent girls.
    Michala L; Argyri E; Tsimplaki E; Tsitsika A; Bakoula C; Antsaklis A; Panotopoulou E
    Gynecol Oncol; 2012 Aug; 126(2):207-10. PubMed ID: 22561405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Brown DR; Elbasha EH; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1585-94. PubMed ID: 20530494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of different HPV types in Turkish women with a normal Pap smear.
    Demir ET; Ceyhan M; Simsek M; Gunduz T; Arlier S; Aytac R; Aycan AE; Gurbuz V
    J Med Virol; 2012 Aug; 84(8):1242-7. PubMed ID: 22711352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.